Liver Cancer Collaborative receives grant
17 February 2026
The Liver Cancer Collaborative (LCC) has been extended for another four years, following $7.8 million funding for its innovative research program that aims to beat primary liver cancer.
Led by clinicians from the Hepatology Department at Sir Charles Gairdner Hospital (SCGH), LCC was established in July 2020 and brings together more than 50 researchers, clinicians and data specialists who bring multidimensional perspectives.
Coordinated through the Harry Perkins Institute of Medical Research, the research project, known as Defeating Primary Liver Cancer, includes clinicians at Sir Charles Gairdner Hospital, Royal Perth Hospital and Fiona Stanley Hospital.
SCGH Hepatologist Clinical A/Professor Michael Wallace said that with sustained support and strong partnerships, the Liver Cancer Collaborative would drive a new era of precision medicine.
“LCC has built a world-leading biobank of ...